All In Biotech

Drug Trial Radar · NCT06185205

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

170

Planned (sponsor's estimate)

Start

Dec 12, 2023

Primary completion

Jan 31, 2031

Study completion Jan 31, 2033

Sponsor

Lead sponsor
Virginia Commonwealth UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 29, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 45 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.

Conditions

  • Breast Cancer

Interventions

  • Accelerated partial breast irradiationDrug

    High Dose Rate treatment delivery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assess the toxicity (at 1 and 3 years) of a 1.5-day APBI treatment courseTime frame: 1 year, and 5 years following irradiation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Virginia Commonwealth University

    Richmond, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.